A recent meta-analysis has demonstrated a significantly heightened risk of adverse prognosis in patients with elevated BNP levels following acute myocardial infarction, underscoring the value of BNP measurement in risk stratification for these patients.14 This evidence concerns the gene NPPB and myocardial infarction.